- © 2007 by American Society of Clinical Oncology
ERRATUM
The January 1, 2007 article by Kondagunta et al entitled, “Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors” (J Clin Oncol 25:85-90, 2007) presented inaccurate results in Figure 2, which should have shown that 51% of patients survived. The corrected figure is reprinted below in its entirety. The online version has been corrected in departure from the print.
Fig 2.
Overall survival curve. Tick marks indicate last follow-up.
